Clinical Trials
26 trialsEXGEFATU
University Hospital Tuebingen
BEAMER
Technical University of Madrid
IRBTR
Children's National Research Institute
EGR2
Assistance Publique - HĂ´pitaux de Paris
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
MPN Research Foundation
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
UNIQUE
University Health Network, Toronto
Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors
Prisma Health-Upstate
SONCO
Assistance Publique - HĂ´pitaux de Paris
Longitudinal Registry Including Patients Treated With Heavy Particles
CNAO National Center of Oncological Hadrontherapy
IRCPSS
University Hospital, Geneva
CoRDS
Sanford Health
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Associazione Angela Serra per la ricerca sul cancro
SarcBOP
University Hospital Heidelberg
PaS
Istituto Ortopedico Rizzoli
PREDICT-LRS
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
STEP 2 0
University Hospital Tuebingen
PsyRareCare
Universitätsklinikum Hamburg-Eppendorf
GE-MED
University Hospital Tuebingen
IonGER
University Hospital Tuebingen
RECAPitNETT
Hospices Civils de Lyon
RELOAD
Istituto Ortopedico Rizzoli
Medication Adherence and Non-adherence in Adults With Rare Disease
Xperiome
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
Associazione Angela Serra per la ricerca sul cancro
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
Associazione Angela Serra per la ricerca sul cancro